Latisse Approved for Longer, Darker Eyelashes
Have you ever wished you had longer, darker lashes? Well, now there is an FDA approved drug that can help you with your wish. Yesterday, Allergan Inc. made the announcement.
The drug, Latisse, can be obtained by prescription only, so will be available through a doctor's office. Allergan expects it's annual sales to reach in the neighborhood of $500 million, helped by its new eyelash growing drug.
Latisse is a applied once-daily to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. Users may begin to see results as early as six to eight weeks. However, it takes 16 weeks to see the full results of grown eyelashes. Latisse should not be applied to the lower lid. Continued use of the drug is necessary to maintain the effect. Lashes will gradually return to pretreatment state if the use of Latisse is discontinued.
The primary ingredient in Latisse, bimatoprost, is a prostaglandin analog that is present in hair and is thought to help in the development and regrowth of hair follicles. The company did warn that the medication should not be applied to the lower eyelid, and that any other part of the body that was exposed to Latisse might show hair growth. Allergan also noted that the eyelashes on each lid might not grow the exact same way.
The only known contraindication for use of Latisse is hypersensitivity to the drug. Approximately 4% of users of Latisse will have side effects such as an itching sensation in the eyes and/or eye redness. Pigmentation of the eyelids and iris may occur. Other less common side effects which typically occur on the skin close to where Latisse is applied, or in the eyes include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new eye condition (e.g., trauma or infection), change in vision, have eye surgery, or develop any eye reactions (e.g. conjunctivitis and eyelid reactions), you should immediately seek your doctor's advice and consider discontinuing use of Latisse for eyelash growth.
Allergan News Release